Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20706873 | 0.99 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20706817 | 0.98 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20821686 | 0.98 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20706889 | 0.96 | PLA2G2A (0.34) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20633756 | 0.94 | HSP90AA1 (0.31) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL22258108 | 0.94 | KDM4E (0.35) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL24400004 | 0.92 | KDM4E (0.35) | KDM4EHSP90AA1HSP90AB1ATML3MBTL1 | |
| SCHEMBL14733882 | 0.90 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL24399875 | 0.90 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20168935 | 0.90 | KDM4E (0.37) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4186898-A1 | COMPOSITION FOR ORGANIC ELECTRONIC COMPOUNDS | Merck Patent GmbH (DE) | 2023-05-31 | — | — | EP | disclosed |
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| EP-3649213-B1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2021-06-23 | — | — | EP | disclosed |
| US-20200216391-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-07-09 | — | — | US | disclosed |
| WO-2019233904-A1 | ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2019-12-12 | — | — | WO | disclosed |
| WO-2019007867-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216391-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | SLCO2B1, SLCO4C1, SLCO2A1 | KDM4E 3376/4885MEN1 2556/4885MAPT 1459/4885 |
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | SLCO2B1, SLCO2A1, SLCO1B3 | KDM4E 3745/4885MEN1 4071/4885MAPT 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.